Manual of industrial microbiology and biotechnology RH Baltz, AL Demain, JE Davies American Society for Microbiology Press, 2010 | 691 | 2010 |
The SARS-CoV-2 vaccine pipeline: an overview WH Chen, U Strych, PJ Hotez, ME Bottazzi Current tropical medicine reports 7 (2), 61-64, 2020 | 659 | 2020 |
Correlates and disparities of intention to vaccinate against COVID-19 T Callaghan, A Moghtaderi, JA Lueck, P Hotez, U Strych, A Dor, ... Social science & medicine (1982) 272, 113638, 2021 | 487 | 2021 |
Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention SM Bartsch, KJ O'shea, MC Ferguson, ME Bottazzi, PT Wedlock, U Strych, ... American journal of preventive medicine 59 (4), 493-503, 2020 | 382 | 2020 |
Recombinant protein vaccines, a proven approach against coronavirus pandemics J Pollet, WH Chen, U Strych Advanced drug delivery reviews 170, 71-82, 2021 | 251 | 2021 |
Status of vaccine research and development of vaccines for leishmaniasis PM Gillespie, CM Beaumier, U Strych, T Hayward, PJ Hotez, ME Bottazzi Vaccine 34 (26), 2992-2995, 2016 | 235 | 2016 |
Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update PJ Hotez, ME Bottazzi, U Strych, LY Chang, YAL Lim, MM Goodenow, ... PLoS neglected tropical diseases 9 (4), e0003575, 2015 | 186 | 2015 |
Correlates and disparities of COVID-19 vaccine hesitancy T Callaghan, A Moghtaderi, JA Lueck, PJ Hotez, U Strych, A Dor, ... Available at SSRN 3667971, 2020 | 171 | 2020 |
Serratia marcescens and its extracellular nuclease MJ Benedik, U Strych FEMS microbiology letters 165 (1), 1-13, 1998 | 148 | 1998 |
Advancing a vaccine to prevent human schistosomiasis M Merrifield, PJ Hotez, CM Beaumier, P Gillespie, U Strych, T Hayward, ... Vaccine 34 (26), 2988-2991, 2016 | 138 | 2016 |
Characterization of the alanine racemases from two mycobacteria U Strych, RL Penland, M Jimenez, KL Krause, MJ Benedik FEMS Microbiology Letters 196 (2), 93-98, 2001 | 131 | 2001 |
Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate WH Chen, SM Chag, MV Poongavanam, AB Biter, EA Ewere, W Rezende, ... Journal of pharmaceutical sciences 106 (8), 1961-1970, 2017 | 118 | 2017 |
The 1.9 Å Crystal Structure of Alanine Racemase from Mycobacterium tuberculosis Contains a Conserved Entryway into the Active Site, P LeMagueres, H Im, J Ebalunode, U Strych, MJ Benedik, JM Briggs, ... Biochemistry 44 (5), 1471-1481, 2005 | 117 | 2005 |
Label-free, in situ SERS monitoring of individual DNA hybridization in microfluidics J Qi, J Zeng, F Zhao, SH Lin, B Raja, U Strych, RC Willson, WC Shih Nanoscale 6 (15), 8521-8526, 2014 | 103 | 2014 |
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice J Pollet, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, J Lee, ... Human vaccines & immunotherapeutics 17 (8), 2356-2366, 2021 | 97 | 2021 |
COVID-19 vaccines: neutralizing antibodies and the alum advantage PJ Hotez, DB Corry, U Strych, ME Bottazzi Nature Reviews Immunology 20 (7), 399-400, 2020 | 93 | 2020 |
Status of vaccine research and development of vaccines for Chagas disease CM Beaumier, PM Gillespie, U Strych, T Hayward, PJ Hotez, ME Bottazzi Vaccine 34 (26), 2996, 2016 | 90 | 2016 |
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches K Rawal, R Sinha, BA Abbasi, A Chaudhary, SK Nath, P Kumari, P Preeti, ... Scientific reports 11 (1), 17626, 2021 | 88 | 2021 |
An aluminum hydroxide: CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice E Nanishi, F Borriello, TR O’Meara, ME McGrath, Y Saito, RE Haupt, ... Science translational medicine 14 (629), eabj5305, 2021 | 87 | 2021 |
Characterization of the Alanine Racemases from Pseudomonas aeruginosa PAO1 U Strych, HC Huang, KL Krause, MJ Benedik Current microbiology 41, 290-294, 2000 | 80 | 2000 |